Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/HCA Healthcare shows strong growth and plans $10B buyback amid regulatory risks

HCA

$382.00

+$3.15 +0.83%

HCA Healthcare shows strong growth and plans $10B buyback amid regulatory risks

Analyst Insights

20 Apr 2026

Seeking Alpha

View Source

Bullish

HCA Healthcare has demonstrated strong multi-year growth in revenue, profits, and cash flow, outperforming the S&P 500 since receiving initial buy ratings. The company plans continued operational improvements and projects 2026 revenue between $76.5 billion and $80 billion, alongside EBITDA growth. Despite approaching fair value compared to peers, HCA is executing a $10 billion share buyback and managing leverage well. Investors should watch for Q1 2026 results and the impact of Medicaid changes and technology investments, as regulatory and reimbursement risks remain a concern.

More News (HCA)

HCA Healthcare upgraded to Buy despite recent struggles, with shares now fairly valued amid policy challenges.

HCA Healthcare's shares have underperformed recently, declining about 4% over the past year and dropping sharply in recent months. The company beat Q2 earnings expectations due to a one-time $400 million Medicaid payment, but underlying margins are p...

Analyst Insights

Neutral

1 day ago